// App-Quantinova.ai

219 : Long-term clinical outcomes associated with sequential treatment of BRAF mutant advanced melanoma patients

Researchers

Presenter

  • Ahmad Tarhini

Principal Investigators

  • David McDermott

  • Apoorva Ambavane

  • Agnes Benedict

  • Cho-Han Lee

  • Corey Ritchings

  • Brian Stwalley

  • Meredith Regan

  • Michael Atkins

Medical Centers

  • H. Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa, FL

  • Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA

  • Evidera, London, UK

  • Bristol-Myers Sqiubb, Princeton, NJ

  • Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA

  • Lombardi Comprehensive Cancer Center, Washington, DC

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Active Comparator

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved